MODERN Labeling Act of 2020
Latest action · Nov 18, 2020 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJan 24, 2020
- Passed HouseNov 17, 2020
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Making Objective Drug Evidence Revisions for New Labeling Act of 2020 or the MODERN Labeling Act of 2020
This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Jan 24, 2020 to Nov 16, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Brett Guthrie | Original | Jan 24, 2020 |
| R-TX | Van Taylor | Nov 16, 2020 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jan 24, 2020Markup Jul 15, 2020Reported Nov 16, 2020 |
| Health Subcommittee | Referred Jan 25, 2020Markup Mar 11, 2020 | |
| Senate | Health, Education, Labor, and Pensions Committee | Referred Nov 18, 2020 |
Actions 15
Everything that happened, newest first.
- Nov 18, 2020Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Nov 17, 2020Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- Nov 17, 2020Considered under suspension of the rules. (consideration: CR H5805-5807)
- Nov 17, 2020DEBATE - The House proceeded with forty minutes of debate on H.R. 5668.
- Nov 17, 2020Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5805-5806)
- Nov 17, 2020Motion to reconsider laid on the table Agreed to without objection.
- Nov 16, 2020Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-573.
- Nov 16, 2020Placed on the Union Calendar, Calendar No. 471.
- Jul 15, 2020Committee Consideration and Mark-up Session Held.
- Jul 15, 2020Ordered to be Reported (Amended) by Voice Vote.
- Mar 11, 2020Ordered to be Reported (Amended) by Voice Vote.
- Mar 11, 2020Subcommittee Consideration and Mark-up Session Held.
- Jan 25, 2020Referred to the Subcommittee on Health.
- Jan 24, 2020Introduced in House
- Jan 24, 2020Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H5805–H5807Text printed H5805 | Anna G. Eshoo D-CA, Brett Guthrie R-KY, Frank Pallone, Jr. D-NJ, Greg Walden R-OR | Nov 17, 2020 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Oct 29, 2020H.R. 5668, Making Objective Drug Evidence Revisions for New Labeling Act of 2020As ordered reported by the House Committee on Energy and Commerce on July 15, 2020
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 166, no. 15, January 24, 2020, page H537.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-93 | IMPROVING SAFETY AND TRANSPARENCY IN AMERICA'S FOOD AND DRUGS350 pages | Energy and Commerce Committee | Jan 29, 2020 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 4
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1895 | Lower Health Care Costs Act | Related bill | Jul 8, 2019 |
| S 1897 | A bill to establish a process for updating the labeling of certain drugs with outdated labeling. | Related bill | Jun 19, 2019 |
| S 4796 | Fair Care Act of 2020 | Related bill | Oct 5, 2020 |
| HR 8527 | Fair Care Act of 2020 | Related bill | Oct 2, 2020 |
Titles 9
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to modernize the labeling of certain generic drugs, and for other purposes.
- Short Title(s) as Introduced
- Making Objective Drug Evidence Revisions for New Labeling Act of 2020
- MODERN Labeling Act of 2020
- Short Title(s) as Reported to House
- MODERN Labeling Act of 2020
- Making Objective Drug Evidence Revisions for New Labeling Act of 2020
- Short Title(s) as Passed House
- Making Objective Drug Evidence Revisions for New Labeling Act of 2020
- MODERN Labeling Act of 2020
- Short Titles from RFS (Referred to Senate) bill text
- Making Objective Drug Evidence Revisions for New Labeling Act of 2020
- MODERN Labeling Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Nov 18, 2020Referred in Senate
- Nov 17, 2020Engrossed in House
- Nov 16, 2020Reported in House
- Jan 24, 2020Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
